The dvm360® pharmacy page is a comprehensive resource for clinical news and insights on the latest veterinary pharmacy. This page consists of articles, videos, interviews that include research on advancements and developments of therapies for veterinary care, and FDA approvals.
The joint decision to expand the MRA's Sectoral Annex for Pharmaceutical Good Manufacturing Practices is a step toward strengthening use of each other’s animal drug inspection expertise and resources
Conditionally approved by the FDA, fuzapladib sodium for injection is a leukocyte function-associated antigen-1 activation inhibitor.
Study results for RJB-01 (Rejuvenate Bio) were announced at the 26th Annual Meeting of the American Society of Gene and Cell Therapy.
The FDA’s recent publication addresses quality control, sterility testing, labeling and other topics relevant to veterinary medications
Newer studies and practice insights are reviewed, along with long-term safety concerns and considerations for future uses.
Zoetis’ bedinvetmab injection is a prescription solution targeting canine nerve growth factor.